There’s no need to go anywhere else for advanced heart care.
At Tallahassee Memorial HealthCare, we are recognized as one of the top complex heart and vascular programs in the Southeast. From our Heart Rhythm Program to our Structural Heart Program, patients travel from around the region to receive their care with our team of experts. Our team is committed to offering the latest treatment options and technology for heart and vascular care. We are also involved in extensive clinical research to help test new technology.
World's Smallest Pacemaker
Only 75 physicians in the country were selected to train using the world’s smallest pacemaker and four of them practice exclusively at TMH. The Micra, about the size of a large vitamin, is implanted directly in the heart through a simple procedure within our EP Lab. Learn more.
TMH was the first hospital in the Southeast, and third commercially in the United States, to implant the WATCHMAN Left Atrial Appendage Closure device since its approval by the Food and Drug Administration (FDA) in March 2015. The WATCHMAN device offers patients with non-valvular atrial fibrillation (AFib) an alternative to long-term anticoagulation therapy (blood thinners such as warfarin) used to reduce the risk of stroke. Patients with AFib have a five times greater risk of stroke. Once implanted, the WATCHMAN device keeps harmful blood clots from entering the blood stream from the left atrial appendage, the most common source for blood clots in AFib patients, in turn reducing the risk of stroke. Learn more.
TMH is one of a few select hospitals in the nation offering transcatheter aortic valve replacement (TAVR) as an option for patients with aortic stenosis who qualify. With TAVR, our multidisciplinary Structural Heart Team uses a catheter to implant the replacement valve through the femoral artery in the groin. TAVR is less invasive, does not require stopping the heart and is associated with a more rapid recovery period than traditional open-heart surgery. Learn more.
Some patients with mitral regurgitation, or a “leaky valve,” may not be a candidate for traditional open heart surgery. However, there is a newer treatment option for these patients with the MitraClip. Performed by our Structural Heart Team, this procedure involves clipping together the valve leaflets to stop the valve from leaking. MitraClip is placed through a small incision in the groin and has a shorter recovery time than open-heart surgery. Learn more.
We use a team model to deliver leading-edge treatment options for patients.
Read More >
At Tallahassee Memorial, each patient has a story to tell. Read the inspiring stories from some of our Heart patients.
Read More >